Home    Health Risk    Drug Response    Athletics    DIYneuroscience    Publications    Studies    Press    Apps    About   

About DIYgenomics

Press


"...'accelerating the professionalization' of do-it-yourself studies" - March 2012

"Ordinary people are taking control of their health data" - December 2011


"A group called DIYgenomics has banded together to analyse their genomes, and even conduct and participate in small clinical trials" - October 2010


"...early adopters are showing how empowering and beneficial to science personal genetic information can be" - September 2010


"...they wanted to build a model trial that could be easily replicated by citizen scientists anywhere" - March 11, 2011

DIYgenomics is a non-profit research organization making personal genomic information useful to individuals. Information is not intended is to replace advice from health professionals. Petition for Access to Genetic Information Genotype prevalence Genome database query Personalized Genomics Apps DIYgenomics provides apps on the web and mobile platforms, some of which include the ability to privately upload 23andMe data for review. The apps feature health risk (a side-by-side comparison of markers reviewed by consumer genomic companies for the top 20 health conditions), drug response (identifying markers associated with metabolism and side effects for 250 drugs), and athletic performance capability. DNA App Stores such as Sequencing.com now provide various personalized genomics apps. Crowdsourced studies (2009-2014) DIYgenomics crowdsourced research studies investigated various areas such as vitamin deficiency, aging, and mental performance. The generalized hypothesis is that one or more genetic polymorphisms (mutations) may result in out-of-bounds phenotypic biomarker conditions (for example, low Vitamin D blood levels), and that personalized intervention may improve this. Studies could restart if health social network collaboration platforms become avilable again. The first study, begun in early 2010, examined two mutations in the MTHFR gene which purportedly lead to Vitamin B-12 deficiency and higher homocysteine levels, and may impact about 60% of the U.S. population. Study participants try a series of interventions and measure the results with blood tests at each phase. The methodology and pilot study results were published in December 2010 and ongoing participation in this and other studies is welcomed.










Website content: Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License
Copyright 1999-2022 DIYgenomics